These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18784736)

  • 1. Hypertensive women with the metabolic syndrome are at risk of renal insufficiency more than men in general population.
    Korhonen P; Aarnio P; Vesalainen R; Saaresranta T; Kautiainen H; Järvenpää S; Kantola I
    J Hum Hypertens; 2009 Feb; 23(2):97-104. PubMed ID: 18784736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
    Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
    BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: the FATH study.
    Gomez P; Ruilope LM; Barrios V; Navarro J; Prieto MA; Gonzalez O; Guerrero L; Zamorano MA; Filozof C;
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S194-200. PubMed ID: 17130261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
    See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
    J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prehypertension is associated with insulin resistance state and not with an initial renal function impairment. A Metabolic Syndrome in Active Subjects in Spain (MESYAS) Registry substudy.
    Cordero A; Laclaustra M; León M; Grima A; Casasnovas JA; Luengo E; del Rio A; Ferreira I; Alegria E
    Am J Hypertens; 2006 Feb; 19(2):189-96; discussion 197-8. PubMed ID: 16448891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes.
    Ryu S; Chang Y; Woo HY; Lee KB; Kim SG; Kim DI; Kim WS; Suh BS; Jeong C; Yoon K
    Am J Kidney Dis; 2009 Jan; 53(1):59-69. PubMed ID: 18838200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease.
    Luk AO; Ma RC; So WY; Yang XL; Kong AP; Ozaki R; Ko GT; Chow CC; Cockram CS; Chan JC; Tong PC
    Diabet Med; 2008 Dec; 25(12):1419-25. PubMed ID: 19046240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
    Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
    J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal function and cardiovascular risk in patients with essential hypertension. The "FRESHA" study].
    Herrero P; Marín R; Fernández Vega F; Gorostidi M; Riesgo A; Vázquez J; Díez Ojeda B;
    Nefrologia; 2006; 26(3):330-8. PubMed ID: 16892821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome and risk of myocardial infarction in familial hypertension (hypertension heredity in Malmö evaluation study).
    Fedorowski A; Burri P; Hulthén L; Melander O
    J Hypertens; 2009 Jan; 27(1):109-17. PubMed ID: 19050451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal dysfunction predicts attenuation of ischemic heart disease mortality risk from elevated glucose among treated hypertensive patients.
    Hailpern SM; Cohen HW; Alderman MH
    Am J Hypertens; 2006 Oct; 19(10):998-1004. PubMed ID: 17027817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of chronic kidney disease in La Réunion island and its association with the metabolic syndrome in the non-diabetic population: La Réunion Diabetes (REDIA) Study.
    Stengel B; Jaussent I; Guiserix J; Bourgeon B; Papoz L; Favier F;
    Diabetes Metab; 2007 Dec; 33(6):444-52. PubMed ID: 18006351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults.
    Kurella M; Lo JC; Chertow GM
    J Am Soc Nephrol; 2005 Jul; 16(7):2134-40. PubMed ID: 15901764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary albumin excretion and glomerular filtration rate across the spectrum of glucose abnormalities in essential hypertension.
    Redon J; Morales-Olivas F; Galgo A; Brito MA; Mediavilla J; Marín R; Rodríguez P; Tranche S; Lozano JV; Filozof C;
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S236-45. PubMed ID: 17130268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
    Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
    Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
    Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome, organ damage and cardiovascular disease in treated hypertensive patients. The ERIC-HTA study.
    Navarro J; Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Bonet A; González-Esteban J
    Blood Press; 2007; 16(1):20-7. PubMed ID: 17453748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.